NEW YORK, Sept. 7, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Lordstown Motors Corp. (“Lordstown” or the “Company”) (OTC Other: RIDEQ) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lordstown investors who…

NEW YORK, Sept. 7, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Lordstown Motors Corp. (“Lordstown” or the “Company”) (OTC Other: RIDEQ) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lordstown investors who…

NEW YORK, Sept. 7, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ: ALDX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Aldeyra investors who were…

NEW YORK, Sept. 7, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ: ALDX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Aldeyra investors who were…

NEW YORK, Sept. 7, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in RTX Corporation f/k/a Raytheon Technologies Corporation (“RTX” or the “Company”) (NYSE: RTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of RTX…

NEW YORK, Sept. 7, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in RTX Corporation f/k/a Raytheon Technologies Corporation (“RTX” or the “Company”) (NYSE: RTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of RTX…

NEW YORK, Sept. 7, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Apellis Pharmaceuticals, Inc. (“Apellis” or the “Company”) (NASDAQ: APLS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Apellis investors who were…

NEW YORK, Sept. 7, 2023 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Apellis Pharmaceuticals, Inc. (“Apellis” or the “Company”) (NASDAQ: APLS) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Apellis investors who were…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.